Structure Therapeutics Inc. Sponsored ADR (GPCR) vs Immunome, Inc. (IMNM)

Structure Therapeutics Inc. Sponsored ADR and Immunome, Inc. are both Biotechnology companies. Structure Therapeutics Inc. Sponsored ADR and Immunome, Inc. are of similar size ($2.6B and $2.6B). Across the 10 metrics below, Structure Therapeutics Inc. Sponsored ADR leads on 7 and Immunome, Inc. on 3.

Valuation

Metric GPCR IMNM Biotechnology median
P/E n/m n/m 7.88
P/S n/m 190.93 11.47
P/B 1.93 4.58 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 149.65 10.73
Earnings yield (8.37%) (11.92%) (28.84%)
Free cash flow yield (8.60%) (9.11%) (23.03%)

Profitability

Metric GPCR IMNM Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (20.21%) (64.03%) (57.72%)
Return on assets (19.17%) (59.03%) (49.22%)
Return on invested capital (1,371.78%) (3,322.99%) 0.00%

Growth

Metric GPCR IMNM Biotechnology median
Revenue growth (TTM) — 16.74% 5.64%
EPS growth (last fiscal year) (2.47%) 51.40% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GPCR IMNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.75 15.08 4.73
Net debt to EBITDA 8.27 2.92 0.96

Dividend

Metric GPCR IMNM Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric GPCR IMNM Biotechnology median
Market cap 2.59b 2.56b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack